Table S5 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S5: Treatment-related probes and samples (Related to Figure 3) S5A: List of 69 IDHmut pairs with treatment information (ID of Initial and Recurrent samples and group assignment) S5B: List of differentially methylated probes associated with treatment in IDHmut gliomas S5C: List of differentially methylated probes associated with treatment in IDHmut astrocytomas S5D: List of CpG-gene pairs (epigenetic regulation associated with treatment)</p

Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

List of collaborator authors</p

Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Supp Figures</p

Table S2 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S2: List of 132 pairs (ID of Initial and Recurrent samples)</p

Table S1 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S1: GLASS surgery-level clinical and molecular characteristics (N=354)</p

Table S4 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S4: Master regulators - list of samples and features (Related to Figure 2) S4A: List of sample profiled for ChIP-seq S4B: Results of H3K4me3 differential analysis S4C: Results of H3K27Ac differential analysis S4D: Results of gene expression differential analysis S4E: List of IDHmut non-codels samples profiled for both gene expression and DNA methylation S4F: List of hypomethylated probes between IDHmut non-codel initial and first recurrent pairs S4G: List of anticorrelated genes S4H: List of HOXD13 predicted targets</p

Table S3 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S3A/B/C/D: Clinical summary of GLASS epigenomic samples S3A: Clinical summary of IDHmut patients who switched from GCIMP-high to GCIMP-low S3B: Clinical summary of IDHmut and IDHwt patients with known hypermutator status S3C: Clinical summary of IDHmut and IDHwt patients with known treatment information S3D: Clinical summary of IDHmut patients with known treatment information</p

Table S6 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Table S6: Deconvolution cell proportions and probe-signature matrix S6A: Methylcibersort cell proportions S6B: Methylcibersort cell reference mixture</p

Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen

Supplemental Figures Legends</p